about
Acetylsalicylic acid (aspirin) for schizophreniaMicroglial Cells as a Link between Cannabinoids and the Immune Hypothesis of Psychiatric DisordersAttachment, Neurobiology, and Mentalizing along the Psychosis ContinuumomicsNPC: Applying the Non-Parametric Combination Methodology to the Integrative Analysis of Heterogeneous Omics Data.In vivo imaging of neuroinflammation in schizophreniaImproving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation.Inflammatory molecular signature associated with infectious agents in psychosis.Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project.Sex differences in TGFB-β signaling with respect to age of onset and cognitive functioning in schizophrenia.Paliperidone prevents brain toll-like receptor 4 pathway activation and neuroinflammation in rat models of acute and chronic restraint stress.The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disordersRetinal microvessels reflect familial vulnerability to psychotic symptoms: A comparison of twins discordant for psychotic symptoms and controls.Association of Lyme Disease and Schizoaffective Disorder, Bipolar Type: Is it Inflammation Mediated?Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controlsBDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year.Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study.Neural circuitry and immunity.Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia.Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.Diurnal Variation and Twenty-Four Hour Sleep Deprivation Do Not Alter Supine Heart Rate Variability in Healthy Male Young AdultsOxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies.Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors.Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders.Brain circuit dysfunction in a distinct subset of chronic psychotic patients.Long-term pathological consequences of prenatal infection: beyond brain disorders.Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment.Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials.The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.Persistent increase in TNF and IL-1 markers in severe mental disorders suggests trait-related inflammation: a one year follow-up study.The renin-angiotensin system: a possible new target for depression.Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [18F]FEPPA.Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms.Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.The Atypical Antipsychotic Paliperidone Regulates Endogenous Antioxidant/Anti-Inflammatory Pathways in Rat Models of Acute and Chronic Restraint Stress.Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model.Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables.Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.
P2860
Q24186077-3D84EAE8-798B-4D66-8D30-3410C0DD439EQ26767489-180DBE21-DFC9-44E7-B42C-ED35A68D2711Q28069770-55491205-1A54-4EB8-A6E1-3AC792ED4EDAQ30827406-62FC4971-57B9-4DEB-801F-ED5CDF70AF68Q30966978-77C3130A-AC6D-4F5B-A798-F0591EE2913BQ31122156-57C17B66-5098-4587-B588-C3335FC1B51CQ34048637-B0038176-1463-4285-B07B-D8EDFEB41DC3Q35096541-CB6A587B-99C8-4535-ABCE-49C0FE471653Q35168712-E45903AB-800C-44B5-93C7-4617BC3EDCB8Q35179057-C0D9AD71-D083-4C9E-A53B-07CF8D285251Q35246024-3343B341-9D6E-4B0D-AB56-3473D699A9D6Q35537155-9163D63E-EA73-41D7-8F52-F964D128AF7EQ35565011-1A6313B7-2202-4E19-94B5-B17F057CB150Q36320164-5FF8AD63-9DB0-4610-80B1-426DF8EBA639Q36377832-A17B3BE3-6BD3-4DDB-B530-97F15CF282ADQ36526417-627B9BD7-AE14-41A8-B823-A8E0FEAEF39AQ36551920-63D71AF9-6979-4771-992B-B03FE2F86A2DQ36579965-05471B9E-049D-4F65-A82A-641002DF954DQ36858447-625711AA-F3B1-411E-91EF-03C5E482087BQ36910682-825510F9-C0E7-411E-A7AC-0E8B18065262Q37621627-89361D7F-1CE2-4941-8D55-F191DF84208DQ38206130-95A0C781-28C1-4A01-A99F-E1BB72C5B5D3Q38208771-76CAFB14-168D-45F3-B441-87F86CE1A890Q38209971-171653DA-934D-4AC7-BE07-4642B9E0306CQ38226241-E6A4A729-0E00-4E93-8C3D-BA155F307853Q38449542-3E566740-172F-4861-AE35-9CE80E37D5B0Q38544976-5CF2F5CE-D911-4414-9C90-14967BED356FQ38545655-64C4F186-68AB-4382-A79B-39828ACF1AA4Q38574561-6565A3BE-EE52-40B1-8572-F6677AD0E3DDQ38620965-88DE04E7-3DA8-40DA-ABC5-A68039356169Q38651269-D128DF65-5EF7-43C8-943A-846CF3AABC6BQ38730353-9D96A2DB-D2DE-484B-B6F3-2CA2A03ADF70Q38805367-D8F1EBC6-5424-4CF0-88DF-6E6505334444Q38809444-A7BB1400-9926-4C1A-98A2-BCED1A83CC9CQ38809746-84A0796A-178B-46A4-81D6-F054D2AA75F9Q38846609-06B0F5DF-DF0D-4630-BE7E-767AED845B2BQ39130393-BC058454-6417-488A-9386-9D8B4E854462Q39166258-175DFAD8-195A-4355-B299-D75A00E8C69DQ39441772-E504CBB3-5505-4E71-892B-358F1C48B233Q40369760-B6CEC069-28BD-44F9-A67A-67BF1A2A2061
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Inflammation and schizophrenia
@ast
Inflammation and schizophrenia
@en
Inflammation and schizophrenia
@nl
type
label
Inflammation and schizophrenia
@ast
Inflammation and schizophrenia
@en
Inflammation and schizophrenia
@nl
prefLabel
Inflammation and schizophrenia
@ast
Inflammation and schizophrenia
@en
Inflammation and schizophrenia
@nl
P2860
P3181
P356
P1476
Inflammation and schizophrenia
@en
P2093
B. J. Miller
P2860
P304
P3181
P356
10.1093/SCHBUL/SBT141
P407
P577
2013-11-01T00:00:00Z